rs73606275
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_003749.3(IRS2):c.*707T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00184 in 202,194 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.0023 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00046 ( 0 hom. )
Consequence
IRS2
NM_003749.3 3_prime_UTR
NM_003749.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 1.73
Publications
2 publications found
Genes affected
IRS2 (HGNC:6126): (insulin receptor substrate 2) This gene encodes the insulin receptor substrate 2, a cytoplasmic signaling molecule that mediates effects of insulin, insulin-like growth factor 1, and other cytokines by acting as a molecular adaptor between diverse receptor tyrosine kinases and downstream effectors. The product of this gene is phosphorylated by the insulin receptor tyrosine kinase upon receptor stimulation, as well as by an interleukin 4 receptor-associated kinase in response to IL4 treatment. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.94).
BS2
High AC in GnomAd4 at 349 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00230 AC: 350AN: 152140Hom.: 0 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
350
AN:
152140
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000461 AC: 23AN: 49936Hom.: 0 Cov.: 0 AF XY: 0.000301 AC XY: 7AN XY: 23218 show subpopulations
GnomAD4 exome
AF:
AC:
23
AN:
49936
Hom.:
Cov.:
0
AF XY:
AC XY:
7
AN XY:
23218
show subpopulations
African (AFR)
AF:
AC:
14
AN:
2136
American (AMR)
AF:
AC:
1
AN:
1362
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3208
East Asian (EAS)
AF:
AC:
1
AN:
8046
South Asian (SAS)
AF:
AC:
0
AN:
424
European-Finnish (FIN)
AF:
AC:
0
AN:
34
Middle Eastern (MID)
AF:
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
AC:
0
AN:
30236
Other (OTH)
AF:
AC:
7
AN:
4174
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.00229 AC: 349AN: 152258Hom.: 0 Cov.: 33 AF XY: 0.00246 AC XY: 183AN XY: 74446 show subpopulations
GnomAD4 genome
AF:
AC:
349
AN:
152258
Hom.:
Cov.:
33
AF XY:
AC XY:
183
AN XY:
74446
show subpopulations
African (AFR)
AF:
AC:
333
AN:
41550
American (AMR)
AF:
AC:
11
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3472
East Asian (EAS)
AF:
AC:
0
AN:
5174
South Asian (SAS)
AF:
AC:
0
AN:
4822
European-Finnish (FIN)
AF:
AC:
0
AN:
10606
Middle Eastern (MID)
AF:
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
AC:
2
AN:
68020
Other (OTH)
AF:
AC:
3
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.